PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 1364422

[Quality tests for ibuprofen preparations].

T Miyazaki·C Yomota·S Okada·T Komuro
View original source ↗Export metadata ↓

Abstract

Ibuprofen preparations were tested with a view to checking their quality by physical methods such as determination, disintegration and dissolution tests. These studies were carried out on 48 kinds of commercial ibuprofen preparations. The drug content of each preparation was measured by spectrophotometry (264nm), and the values were in the range of 90-110%. In the disintegration tests of 36 tablets, a few tablets of two preparations failed to disintegrate completely after 60 minutes. However the number of such tablets was within the limit specified in JP. The dissolution test described in the USP monograph was also applied to the 36 tablets, and it was found that 9 tablets failed the test provision that over 70% of the tablets must be dissolved within 30 minutes.

Explore related subjects

IbuprofenSolubilitySpectrophotometryTabletsEnglish AbstractJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

T Miyazaki, C Yomota, S Okada, T Komuro. 1992. [Quality tests for ibuprofen preparations].. https://pubmed.ncbi.nlm.nih.gov/1364422/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Influence of granulation and compaction on the particle size of ibuprofen--development of a size analysis method.

The aim of this work was to study the impact of the process on drug particle size. We chose ibuprofen, practically insoluble in water, as granulometry greatly influences its dissolution rate. We developed an original method using a laser granulometer to assess the size of ibuprofen within a blend before and after granulation and then compression. Wet granulation was performed with a Lodige and a Diosna granulator. The granules were then compressed. The evolution of ibuprofen particle size after these operations was checked. Two grades of ibuprofen differing in size were studied: ibuprofen 25 and ibuprofen 50. After the wet granulation of ibuprofen 50 with a Lodige or a Diosna granulator, a decrease in size was observed. This could be caused by shocks occurring in the granulator. On the other hand, after compression of the granules, ibuprofen particle size increased and was greater than that measured before granulation. Compression could induce some fragmentation of ibuprofen associated with the plastic deformation and then, under pressure, a closeness of the fragments or deformed particles which could bind or associate with one another because the melting point of ibuprofen is not very high. In the case of ibuprofen 25, the same phenomena were observed after compression. But, after granulation, particle size was not modified. There was little breaking of ibuprofen particles in the granulator because they are much smaller than those of ibuprofen 50. This work shows the impact of the process on drug particle size when producing tablets. The method developed made it possible to differentiate and measure the size of ibuprofen particles in a blend.

Ibuprofen↗
PubMed2006

Experimental and theoretical investigation of the micellar-assisted solubilization of ibuprofen in aqueous media.

Surfactants can be used to increase the solubility of poorly soluble drugs in water and to increase drug bioavailability. In this article, the aqueous solubilization of the nonsteroidal, antiinflammatory drug ibuprofen is studied experimentally and theoretically in micellar solutions of anionic (sodium dodecyl sulfate, SDS), cationic (dodecyltrimethylammonium bromide, DTAB), and nonionic (dodecyl octa(ethylene oxide), C12E8) surfactants possessing the same hydrocarbon "tail" length but differing in their hydrophilic headgroups. We find that, for these three surfactants, the aqueous solubility of ibuprofen increases linearly with increasing surfactant concentration. In particular, we observed a 16-fold increase in the solubility of ibuprofen relative to that in the aqueous buffer upon the addition of 80 mM DTAB and 80 mM C12E8 but only a 5.5-fold solubility increase upon the addition of 80 mM SDS. The highest value of the molar solubilization capacity (chi) was obtained for DTAB (chi = 0.97), followed by C12E8 (chi = 0.72) and finally by SDS (chi = 0.23). A recently developed computer simulation/molecular-thermodynamic modeling approach was extended to predict theoretically the solubilization behavior of the three ibuprofen/surfactant mixtures considered. In this modeling approach, molecular-dynamics (MD) simulations were used to identify which portions of ibuprofen are exposed to water (hydrated) in a micellar environment by simulating a single ibuprofen molecule at an oil/water interface (modeling the micelle core/water interface). On the basis of this input, molecular-thermodynamic modeling was then implemented to predict (i) the micellar composition as a function of surfactant concentration, (ii) the aqueous solubility of ibuprofen as a function of surfactant concentration, and (iii) the molar solubilization capacity (chi). Our theoretical results on the solubility of ibuprofen in aqueous SDS and C12E8 surfactant solutions are in good agreement with the experimental data. The ibuprofen solubility in aqueous DTAB solutions was somewhat overpredicted because of challenges associated with accurately modeling the strong electrostatic interactions between the anionic ibuprofen and the cationic DTAB. Our results indicate that computer simulations of ibuprofen at a flat oil/water interface can be used to obtain accurate information about the hydrated and the unhydrated portions of ibuprofen in a micellar environment. This information can then be used as input to a molecular-thermodynamic model of self-assembly to successfully predict the aqueous solubilization behavior of ibuprofen in the three surfactant systems studied.

Ibuprofen↗
PubMed2006

[Study on ion beam mutagenizing of the Trichosporon lactis T for enantioselective separation of ibuprofen].

The initial strain, Trichosporon Lactis T, isolated from soil sample, having the capability of enantioselectively hydrolyzing S-isomer of racemic ibuprofen ethyl-ester into the corresponding S-ibuprofen, was implanted by 30 KeV, 1 x 10(15) ions/cm2 - 5 x 10(15) ions/cm2 low-energy N+ for the purpose of obtaining mutants with high-efficiency hydrolyzing enzyme to produce active S-ibuprofen. Under the dosage of 30 KeV, 4 x 10(15) ions/cm2, the mutation rate is the highest, with 32.9 % positive and 37.1% negative mutant, respectively. Therefore, 30 KeV, 4 x 10(15) ions/cm2 is chosen as the optimal implantation dosage. Under optimal implantation dosage, seven mutants with high-efficiency hydrolyzing enzyme are selected after N+ implantation. The genetic stability test shows that T. lactis K1, one of the seven mutants, has a stable hydrolyzing ability during consecutive five-generation. The enzyme activity of T. lactis K1 is higher with 50% than that of the initial strain after 24 h cultivation, and the highest enzyme activity of T. lactis K1 appears 6h earlier than that of the initial strain. After 24 h cultivation and succeeding 24 h incubation with ibuprofen ethyl ester, the S-ibuprofen production of T. lactis K1 is 6.96 g/L, 64.2% higher than that of T. lactis T, which only produces 4.24 g/L S-ibuprofen at the same time, the specific rotation and enantiomeric excess (ee%) of the S-ibuprofen produced by two stains, however, are the same, + 54.1 degrees and 98%, respectively.

Ibuprofen↗